
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Community, Occupational and Family Medicine, Faculty of Medicine, National University of Singapore, Singapore 117597 [B. Z., A. S., H-P. L.]; Departments of Pharmacology [E. J. D. L.], Pathology [M. T.], and Medicine [W-C. T.], Faculty of Medicine, National University of Singapore, Singapore 119260; Departments of Pathology [W-T. P.] and Respiratory and Critical Care Medicine [P. E.], Singapore General Hospital, Singapore 169608; Department of Respiratory Medicine, Tan Tock Seng Hospital, Singapore 308433 [Y-T. W.]; and University of Southern California/Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California 90033-0800 [M. C. Y.]
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
ITCs are among the most effective chemopreventive agents known. Their chemopreventive effect has been attributed to their ability to inhibit phase I enzymes that are responsible for the bioactivation of carcinogens and to induce phase II detoxification enzymes (6) . Experimental studies in animals have demonstrated the efficacy of ITCs in inhibiting lung carcinogensis by known carcinogens, such as polycyclic aromatic hydrocarbons and NNK (5) .
Human GSTs are phase II enzymes that play a major role in the detoxification of many reactive electrophilic compounds by conjugation with glutathione and also by noncovalent binding of many xenobiotics (7) . GSTs can be classified into at least four genetically distinct groups (8) including GSTM1 and GSTT1. Polymorphisms in the GSTM1 and GSTT1 genes are caused by a complete deletion of the gene, which results in the loss of function (10 , 11) . Deficiency in GSTM1 and GSTT1 isoenzyme activity may predispose to the effects of electrophilic carcinogens and has been reported to be possibly associated with an increased susceptibility to lung cancer in some, but not all, studies (12) . Induction of the GST class of enzymes is one of the important mechanisms by which ITCs inhibit carcinogenesis (13) .
Interestingly, the GST family also encompasses key enzymes in the metabolism of ITCs in humans and demonstrate considerable substrate specificity for these compounds (14 , 15) . Conjugation of ITCs with glutathione is the first step leading to the formation of the corresponding N-acetylcysteine conjugates (dithiocarbamates) and aids in the elimination of ITCs (15) . Hence the GSTs promote the elimination not only of carcinogens, but also of ITCs themselves (16) , and could thus decrease ITC chemopreventive effects. Modification of the ITC-mediated protective effect in lung cancer by GSTM1 and GSTT1 polymorphisms is biologically plausible and has been reported in two recent epidemiological studies, Refs. 17 and 18 , among Shanghai Chinese men, and United States whites, respectively.
Lung cancer is currently the third most commonly diagnosed cancer among Singapore Chinese women and constitutes 9.8% of all cancers in this population (19) . This population is unique in having an incidence of lung cancer comparable with many countries in the West despite a smoking prevalence of only 3% (20) . It is also characterized by a high intake of cruciferous vegetables; the mean intake frequency being 363 times a year (and the average amount 42.5 g/day) among Chinese women. We previously demonstrated, in the same population, that individuals with GSTT1-non-null genotype had significantly higher levels of urinary ITCs when stratified by dietary intake of ITCs or cruciferae, suggesting that GSTT1 is a key enzyme in the conjugation and subsequent excretion of these compounds (21) . In the present study, we determined the intake of ITCs obtained by dietary questionnaire from 420 Chinese women (233 lung cancer cases and 187 controls), and we used PCR-based methods to determine their GSTM1 and GSTT1 genotypes. We examined the relationship between total ITC intake and lung cancer risk in Chinese women and the effect of GSTM1 and GSTT1 polymorphisms on this risk.
| Subjects and Methods |
|---|
|
|
|---|
Demographic information and data on smoking were obtained by standardized questionnaire administered in-person by a research nurse, who interviewed both cases and controls equally. For cases, interviews took place within 3 months of diagnosis of cancer. Interviewers were not blind to case or control status, but possible observer bias was monitored by tape-recording and review of a random sample of interviews. Subjects were classified as smokers if they had ever smoked at least one cigarette a day for 1 year or more. Ex-smokers were smokers who had stopped smoking for 1 year or more. Pathology specimens of all cases were reviewed and classified independently by two study pathologists; only pathologically confirmed cases with a diagnosis of squamous cell carcinoma, small cell carcinoma, adenocarcinoma, or large cell carcinoma were included.
| Dietary Data. |
|---|
|
|
|---|
| Identification of GSTM1 and GSTT1 Genotypes. |
|---|
|
|
|---|
The GSTM1-null genotype was determined by procedures described by Groppi et al. (25) with a slight modification. Briefly, two primers that hybridize within the fourth intron (1019: 5'-GAA GGT GGC CTC CTC CTT GG) and in the 3' region of the fifth exon (526: 5'-AAT TCT GGA TTG TAG CAG AT) were used in the presence of another pair of primers (5'-ACA CAA CTG TGT TCA CTA GC-3' and 5'-CTC AAA GAA CCT CTG GGT CC-3') to amplify ß-globin, included in the assay as a positive control for target DNA. A PCR reaction (amplification size: 165 bp for GSTM1 presence; 299 bp for ß-globin) was performed to detect the GSTM1 deletion mutation at exon 5.
GSTT1-null genotype was determined using a similar modification of a PCR approach described previously (11) , with the addition of primers for a ß-globin control fragment (299 bp). The primers used to amplify the target DNA were: 5'-TTC CTT ACT GGT CCT CAC ATC TC (468491) and 5'-TCA CCG GAT CAT GGC CAG CA (703723). The presence of at least one GSTT1 allele was identified by a 480-bp PCR product.
The presence or absence of the GSTM1 and GSTT1 genes was analyzed by ethidium bromide 1.6% agarose gel electrophoresis. All stages of the analysis were carried out blind to the patients disease status.
| Statistical Analysis. |
|---|
|
|
|---|
| Results |
|---|
|
|
|---|
|
Among the 420 study subjects, the distribution of estimated weekly intake level of ITCs was unimodal and markedly skewed to the right, with a range of 0.0449.0 µmol and a median of 53.0 µmol. There was a 9.8-fold difference between the 90th and the 10th percentiles in the distribution. Table 2
shows the effect of weekly intake of ITCs on lung cancer risk. For subjects who reported an intake above the median value for controls, the risk of lung cancer was reduced. For all women, the age- and smoking-adjusted OR was 0.63 (95% CI, 0.410.95). The protection afforded by higher ITC intake was more marked among ever-smokers (OR, 0.31; 95% CI, 0.100.96) than among lifetime nonsmokers (OR, 0.70; 95% CI 0.451.11). Additional adjustment for place of birth did not materially affect the estimates.
|
|
| Discussion |
|---|
|
|
|---|
Overall, our data demonstrate a significant association between dietary ITC intake and lung cancer risk. The stronger effect in smokers is not surprising, and it is consistent with the evidence that ITCs are known to reduce lung carcinogenesis by tobacco-related carcinogens. Polycyclic aromatic hydrocarbons such as benzo(a)pyrene and NNK, a tobacco-specific nitrosamine, require metabolic activation. Agents such as ITC, which decrease formation of the electrophilic DNA binding intermediates, reduce DNA damage and thereby inhibit carcinogenesis. Mechanistic studies have shown that this chemopreventive activity is attributable to the inhibition of phase I enzymes and the induction of phase II enzymes (6) . Specifically, phenethyl ITC has been shown to inhibit NNK-induced lung tumorigenesis in animal studies (27 , 28) , and the consumption of watercress by smoking volunteers led to increased urinary excretion of NNK metabolites (5) .
The most thoroughly studied examples of ITC inhibition of carcinogenesis are in relation to tobacco-related carcinogens (29) , and the evidence linking ITC to lung cancer risk among nonsmokers is less consistent than for smokers. However, the experimental evidence does point to the capability of ITCs to inhibit carcinogenesis in a wide range of target organs and against a variety of chemical carcinogens (29) . Among the epidemiological studies of Brassica vegetable intake and lung cancer that have examined risk among nonsmokers or within smoking strata, there has been no clear evidence of an inverse relationship among nonsmokers (2 , 30 , 31) . Compared with most of these studies, the current study population has a relatively high intake of cruciferae (21) . We show that in the subgroup of nonsmokers who are null for GSTM1, high intake of ITC reduces risk by nearly 50%. The effect is unlikely to be caused by ETS exposure. Among the nonsmokers in our study population, 127 (41.5%) reported ever being exposed to ETS at home on a daily basis. When we examined GSTM1-null individuals stratified by this variable, the association with ITC was not confined to, or stronger among, those who had been exposed to ETS daily (age-adjusted OR, 0.65; 95% CI, 0.271.59) than among those had never been exposed or were infrequently exposed to ETS (OR, 0.47; 95% CI, 0.211.01). Adjusting for the intake of total fruit and vegetable intake (number of standard servings weekly) also did not materially affect the estimates (OR, 0.52; 95% CI, 0.290.95), indicating that the inverse association between ITC and lung cancer risk among GSTM1-null nonsmokers is not likely to be merely a surrogate for the effects of other nutrients in fruit and vegetables.
Apart from its effects on carcinogen metabolism, ITCs have been shown to induce apoptosis and influence protein kinase activities (32 , 33) , suggesting that they may play a role in various stages of the carcinogenic process. The mechanisms by which ITCs exert their effect in nonsmokers deserve additional study and may provide useful clues to the etiology of lung cancer in these women.
A key finding in this report is the interaction between GST genotype and the reduction in risk of lung cancer by ITC intake. Two other recent studies (17 , 18) have described a similar observation. London et al. (17) showed that, among Chinese men in Shanghai, individuals with detectable urinary ITCs had a significantly reduced risk of lung cancer, and that this effect was primarily confined to individuals with GSTM1- or -T1- (or both) null genotypes. Similarly, in a United States population, Spitz et al. (18) found that a combination of low ITC intake and GSTM1- and -T1-null genotypes conferred the highest risk of lung cancer among smokers. Our study extends these findings to a population of Chinese women, of whom a large proportion are nonsmokers, and the results are consistent with the theoretical framework that elimination of ITCs by GST results in an attenuation of their protective effect.
One of the strengths of the current study is the inclusion of only pathologically confirmed, incident lung cancer cases, whereas its limitations include those inherent in a retrospective study. The use of hospital controls may have introduced bias if controls suffered from conditions systematically related to higher or lower cruciferous vegetable intake. We drew controls from a wide variety of disciplines to minimize the likelihood of such bias, and we also note that the distribution of ITC intake among controls is not dependent on GST genotype and does not explain the effect modification observed. We have attempted to measure ITC intake based on a variety of cruciferous vegetables commonly eaten locally, and we have based our estimates of ITC intake on actual quantification of ITC content in each of these nine vegetables.
In conclusion, our results provide additional evidence that ITCs from cruciferous vegetable consumption protect against lung cancer, and we extend these findings to a Chinese population with a high proportion of lifetime nonsmokers. In addition, ITC intake and GSTM1 and GSTT1 polymorphisms interact in the etiology of lung cancer such that persons with the null genotype experience a greater reduction in risk because these compounds are less rapidly metabolized and eliminated from the body.
| Acknowledgments |
|---|
| Footnotes |
|---|
1 This study was funded by Research Grant NMRC 1996/0155 from the National Medical Research Council, Singapore. Dr. Mimi Yu is supported by United States National Cancer Institute Grant R35 CA53890. ![]()
2 To whom requests for reprints should addressed, at Department of Community, Occupational and Family Medicine, Faculty of Medicine, The National University of Singapore, MD3, 16 Medical Drive, Singapore 117597. Email: cofseowa{at}nus.edu.sg ![]()
3 The abbreviations used are: ITC, isothiocyanate; NNK, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone; GST, glutathione S-transferase; OR, odds ratio; CI, confidence interval; ETS, environmental tobacco smoke. ![]()
Received 4/20/01; revised 7/19/01; accepted 8/16/01.
| References |
|---|
|
|
|---|
]pyrene-4,5-oxide. Biochem. Biophys. Res. Commun., 98: 512-519, 1981.[Medline]
(GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem. J., 300: 271-276, 1994.
This article has been cited by other articles:
![]() |
U. Telang, D. A. Brazeau, and M. E. Morris Comparison of the Effects of Phenethyl Isothiocyanate and Sulforaphane on Gene Expression in Breast Cancer and Normal Mammary Epithelial Cells Experimental Biology and Medicine, March 1, 2009; 234(3): 287 - 295. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. K. Lam, L. Gallicchio, K. Lindsley, M. Shiels, E. Hammond, X. Tao, L. Chen, K. A. Robinson, L. E. Caulfield, J. G. Herman, et al. Cruciferous Vegetable Consumption and Lung Cancer Risk: A Systematic Review Cancer Epidemiol. Biomarkers Prev., January 1, 2009; 18(1): 184 - 195. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-M. Lee, D. Kang, M. L. Clapper, M. Ingelman-Sundberg, M. Ono-Kihara, C. Kiyohara, S. Min, Q. Lan, L. Le Marchand, P. Lin, et al. CYP1A1, GSTM1, and GSTT1 Polymorphisms, Smoking, and Lung Cancer Risk in a Pooled Analysis among Asian Populations Cancer Epidemiol. Biomarkers Prev., May 1, 2008; 17(5): 1120 - 1126. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Carlsten, G. S. Sagoo, A. J. Frodsham, W. Burke, and J. P. T. Higgins Glutathione S-Transferase M1 (GSTM1) Polymorphisms and Lung Cancer: A Literature-based Systematic HuGE Review and Meta-Analysis Am. J. Epidemiol., April 1, 2008; 167(7): 759 - 774. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Munday, P. Mhawech-Fauceglia, C. M. Munday, J. D. Paonessa, L. Tang, J. S. Munday, C. Lister, P. Wilson, J. W. Fahey, W. Davis, et al. Inhibition of Urinary Bladder Carcinogenesis by Broccoli Sprouts Cancer Res., March 1, 2008; 68(5): 1593 - 1600. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.E. Steck, M.M. Gaudet, J.A. Britton, S.L. Teitelbaum, M.B. Terry, A.I. Neugut, R.M. Santella, and M.D. Gammon Interactions among GSTM1, GSTT1 and GSTP1 polymorphisms, cruciferous vegetable intake and breast cancer risk Carcinogenesis, September 1, 2007; 28(9): 1954 - 1959. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Alberg, J. G. Ford, and J. M. Samet Epidemiology of Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 29S - 55S. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Gasper, M. Traka, J. R. Bacon, J. A. Smith, M. A. Taylor, C. J. Hawkey, D. A. Barrett, and R. F. Mithen Consuming Broccoli Does Not Induce Genes Associated with Xenobiotic Metabolism and Cell Cycle Control in Human Gastric Mucosa J. Nutr., July 1, 2007; 137(7): 1718 - 1724. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Steck, M. D. Gammon, J. R. Hebert, D. E. Wall, and S. H. Zeisel GSTM1, GSTT1, GSTP1, and GSTA1 Polymorphisms and Urinary Isothiocyanate Metabolites following Broccoli Consumption in Humans J. Nutr., April 1, 2007; 137(4): 904 - 909. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. I. Gill, S. Haldar, L. A Boyd, R. Bennett, J. Whiteford, M. Butler, J. R Pearson, I. Bradbury, and I. R Rowland Watercress supplementation in diet reduces lymphocyte DNA damage and alters blood antioxidant status in healthy adults Am. J. Clinical Nutrition, February 1, 2007; 85(2): 504 - 510. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Raimondi, V Paracchini, H Autrup, J. Barros-Dios, S Benhamou, P Boffetta, M. Cote, I. Dialyna, V Dolzan, R Filiberti, et al. Meta- and Pooled Analysis of GSTT1 and Lung Cancer: A HuGE-GSEC Review Am. J. Epidemiol., December 1, 2006; 164(11): 1027 - 1042. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. B. Ambrosone Epidemiological evidence for chemopreventive effects of cruciferous vegetables on cancer risk. AACR Meeting Abstracts, April 1, 2006; 2006(1): 1365 - 1365. [Abstract] |
||||
![]() |
J. Tujague, M. Bastaki, N. Holland, J. R. Balmes, and I. B. Tager Antioxidant intake, GSTM1 polymorphism and pulmonary function in healthy young adults Eur. Respir. J., February 1, 2006; 27(2): 282 - 288. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V Gasper, A. Al-janobi, J. A Smith, J. R Bacon, P. Fortun, C. Atherton, M. A Taylor, C. J Hawkey, D. A Barrett, and R. F Mithen Glutathione S-transferase M1 polymorphism and metabolism of sulforaphane from standard and high-glucosinolate broccoli Am. J. Clinical Nutrition, December 1, 2005; 82(6): 1283 - 1291. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Conaway, C.-X. Wang, B. Pittman, Y.-M. Yang, J. E. Schwartz, D. Tian, E. J. McIntee, S. S. Hecht, and F.-L. Chung Phenethyl Isothiocyanate and Sulforaphane and their N-Acetylcysteine Conjugates Inhibit Malignant Progression of Lung Adenomas Induced by Tobacco Carcinogens in A/J Mice Cancer Res., September 15, 2005; 65(18): 8548 - 8557. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Alberg, M. V. Brock, and J. M. Samet Epidemiology of Lung Cancer: Looking to the Future J. Clin. Oncol., May 10, 2005; 23(14): 3175 - 3185. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Tseng, E. A. Scott-Ramsay, and M. E. Morris Dietary Organic Isothiocyanates Are Cytotoxic in Human Breast Cancer MCF-7 and Mammary Epithelial MCF-12A Cell Lines Experimental Biology and Medicine, September 1, 2004; 229(8): 835 - 842. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Tang and Y. Zhang Dietary Isothiocyanates Inhibit the Growth of Human Bladder Carcinoma Cells J. Nutr., August 1, 2004; 134(8): 2004 - 2010. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Hecht, S. G. Carmella, P. M.J. Kenney, S.-H. Low, K. Arakawa, and M. C. Yu Effects of Cruciferous Vegetable Consumption on Urinary Metabolites of the Tobacco-Specific Lung Carcinogen 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone in Singapore Chinese Cancer Epidemiol. Biomarkers Prev., June 1, 2004; 13(6): 997 - 1004. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Shukla, B. Srivastava, A. Arora, and L K. Chauhan Protective effects of indole-3-carbinol on cyclophosphamide-induced clastogenecity in mouse bone marrow cells Human and Experimental Toxicology, May 1, 2004; 23(5): 245 - 250. [Abstract] [PDF] |
||||
![]() |
C. B. Ambrosone, S. E. McCann, J. L. Freudenheim, J. R. Marshall, Y. Zhang, and P. G. Shields Breast Cancer Risk in Premenopausal Women Is Inversely Associated with Consumption of Broccoli, a Source of Isothiocyanates, but Is Not Modified by GST Genotype J. Nutr., May 1, 2004; 134(5): 1134 - 1138. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Miyoshi, S. Takabayashi, T. Osawa, and Y. Nakamura Benzyl isothiocyanate inhibits excessive superoxide generation in inflammatory leukocytes: implication for prevention against inflammation-related carcinogenesis Carcinogenesis, April 1, 2004; 25(4): 567 - 575. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Brennan Commentary: Mendelian randomization and gene-environment interaction Int. J. Epidemiol., February 1, 2004; 33(1): 17 - 21. [Full Text] [PDF] |
||||
![]() |
M. L. Neuhouser, R. E. Patterson, M. D. Thornquist, G. S. Omenn, I. B. King, and G. E. Goodman Fruits and Vegetables Are Associated with Lower Lung Cancer Risk Only in the Placebo Arm of the {beta}-Carotene and Retinol Efficacy Trial (CARET) Cancer Epidemiol. Biomarkers Prev., April 1, 2003; 12(4): 350 - 358. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Boysen, P. M.J. Kenney, P. Upadhyaya, M. Wang, and S. S. Hecht Effects of benzyl isothiocyanate and 2-phenethyl isothiocyanate on benzo[a]pyrene and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone metabolism in F-344 rats Carcinogenesis, March 1, 2003; 24(3): 517 - 525. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Seow, J.-M. Yuan, C.-L. Sun, D. Van Den Berg, H.-P. Lee, and M. C. Yu Dietary isothiocyanates, glutathione S-transferase polymorphisms and colorectal cancer risk in the Singapore Chinese Health Study Carcinogenesis, December 1, 2002; 23(12): 2055 - 2061. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Lampe and S. Peterson Brassica, Biotransformation and Cancer Risk: Genetic Polymorphisms Alter the Preventive Effects of Cruciferous Vegetables J. Nutr., October 1, 2002; 132(10): 2991 - 2994. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Thimmulappa, K. H. Mai, S. Srisuma, T. W. Kensler, M. Yamamoto, and S. Biswal Identification of Nrf2-regulated Genes Induced by the Chemopreventive Agent Sulforaphane by Oligonucleotide Microarray Cancer Res., September 15, 2002; 62(18): 5196 - 5203. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |